Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapy Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Clinical Trials as Topic
  • Health Care Costs
  • Leukemia, Myeloid, Acute

abstract

  • Although charges for the nonprotocol group were higher, specific factors responsible for this difference were not identified. This study emphasizes the problems inherent in assembling suitable groups of patients for comparison.

publication date

  • September 2002

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.10805

PubMed ID

  • 12209692

Additional Document Info

start page

  • 1064

end page

  • 70

volume

  • 95

number

  • 5